Search For "drug"
After spending nearly 10 years in prison, two foreigners acquitted by Delh
Updated : 6 years, 2 months ago IST
New Delhi [India], May 18 (ANI): Two foreign nationals, who spent nearly the entire past decade in prison serving their sentence in a Narcotics Drugs and Psychotropic Substances Act case, have been acquitted of all charges by Delhi High Court.
Read More
Maharashtra govt approves formation of AYUSH task force
Updated : 6 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 18 (ANI): The Maharashtra government has approved the formation of a task force which will give recommendations to it to incorporate AYUSH treatment modalities specifically for increasing immunity against COVID-19, said the state medical education and drug d
Read More
Govts, drugmakers under pressure to roll out effective COVID vaccines
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], May 18 (ANI): Governments and drugmakers are considering ways how to roll out effective coronavirus vaccines and build capacity to make millions of its doses available in the United States starting as soon as this fall. Yet there isn't a guarantee that any of the most
Read More
Researchers find new imaging tool to see extent of Alzheimer's early damag
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], May 17 (ANI): In a novel finding that may pave way for drug development, researchers have developed a new imaging technology that allows scientists to see the widespread loss of brain synapses in early stages of Alzheimer's disease.
Read More
Hydroxychloroquine --promoted by Trump as Covid 'game changer'-- linked to
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], May 17 (ANI): Clinical trials of the anti-malarial drug or hydroxychloroquine, which gained prominence overnight after being promoted by US President Donald Trump as a 'game changer' in the fight against Covid-19, have been significantly linked to cardiac problems and
Read More
'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir,
Updated : 6 years, 2 months ago IST
New Delhi [India], May 15 (ANI): The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the treatment of COVID-19 patients.
Read More
Uttar Pradesh seeks details of people buying medicines for fever, cold fro
Updated : 6 years, 2 months ago IST
Lucknow (Uttar Pradesh) [India], May 15 (ANI): Amid COVID-19 outbreak, Uttar Pradesh Food Safety and Drug Administration has instructed drug inspectors to submit details about buyers of medicines for fever, cold and cough, on a daily basis from drug stores in their respective areas.
Read More
Trump administration failed to scale up in time to distribute COVID-19 dru
Updated : 6 years, 2 months ago IST
Washington DC [USA], May 15 (Sputnik/ANI): There are not enough doses of the coronavirus trial drug remdesivir because the Trump administration failed to ramp up production and lacks a distribution plan, former government vaccine developer Rick Bright said on Thursday.
Read More
J-K to have anti-narcotics task force
Updated : 6 years, 3 months ago IST
Srinagar (Jammu and Kashmir) [India], May 14 (ANI): As part of efforts to fight drug menace in the Union Territory, Jammu and Kashmir administration on Thursday accorded sanction to setting up of Anti Narcotics Task Force (ANTF) under the overall superintendence and control of Inspector Gene
Read More
With new approaches against Coronavirus, doctors express 'glimmers of hope
Updated : 6 years, 3 months ago IST
Washington D.C. [US], May 14 (ANI): Those on the frontline in the battle against coronavirus are expressing "glimmers of hope" as far as the treatment of COVID-19 patients is concerned.
Read More
Microsoft grant for COVID-19 research to Shoolini Univ Scientists
Updated : 6 years, 3 months ago IST
Solan (Himachal Pradesh) [India], May 13 (ANI/PRNewswire): A team of scientists from Himachal Pradesh-based Shoolini University has been offered a grant through Microsoft Artificial Intelligence for Health Programme to conduct research on finding drugs to cure and prevent COVID19.
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 6 years, 3 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More